Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized perioperative tranexamic acid dosing regimens in total knee and hip arthroplasty
ChiCTR-IPR-17011896Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in osteoarthritis (OA) (8 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Intraoperative blood loss, Postoperative drainage volume and 6 more. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-17011896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011896.